• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Questions raised by the Benelux CML Study Group: results from the randomized study with hydroxyurea alone versus hydroxyurea combined with low-dose interferon-alpha2b for chronic myeloid leukemia.

作者信息

Kantarjian H M, Talpaz M

出版信息

Blood. 1998 Oct 15;92(8):2984-7.

PMID:9763593
Abstract
摘要

相似文献

1
Questions raised by the Benelux CML Study Group: results from the randomized study with hydroxyurea alone versus hydroxyurea combined with low-dose interferon-alpha2b for chronic myeloid leukemia.比荷卢慢性粒细胞白血病研究小组提出的问题：单用羟基脲与羟基脲联合低剂量α-2b干扰素治疗慢性粒细胞白血病的随机研究结果
Blood. 1998 Oct 15;92(8):2984-7.
2
Interferon alfa versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials: Chronic Myeloid Leukemia Trialists' Collaborative Group.干扰素α与化疗治疗慢性髓性白血病的比较：七项随机试验的荟萃分析：慢性髓性白血病试验协作组
J Natl Cancer Inst. 1997 Nov 5;89(21):1616-20.
3
Randomized study on hydroxyurea alone versus hydroxyurea combined with low-dose interferon-alpha 2b for chronic myeloid leukemia. The Benelux CML Study Group.羟基脲单药与羟基脲联合低剂量α-干扰素-2b治疗慢性粒细胞白血病的随机研究。比荷卢慢性粒细胞白血病研究组。
Blood. 1998 Apr 15;91(8):2713-21.
4
Current aspects of drug therapy in Philadelphia-positive CML: correlation of tumor burden with survival.费城染色体阳性慢性粒细胞白血病的当前药物治疗现状：肿瘤负荷与生存率的相关性
Leuk Lymphoma. 1996 Sep;22 Suppl 1:161-7. doi: 10.3109/10428199609074374.
5
Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea.干扰素α与羟基脲联合治疗与羟基脲单药治疗慢性粒细胞白血病的随机对照研究（CML研究II）：干扰素α与羟基脲联合治疗可延长生存期
Leukemia. 2003 Aug;17(8):1529-37. doi: 10.1038/sj.leu.2403006.
6
Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.在慢性粒细胞白血病患者接受未处理造血细胞自体移植后，使用粒细胞巨噬细胞集落刺激因子（GM-CSF）联合羟基脲作为移植后治疗方法。
Haematologica. 1997 May-Jun;82(3):291-6.
7
Optimizing treatment for chronic myeloid leukemia.
N Engl J Med. 1997 Jul 24;337(4):270-1. doi: 10.1056/NEJM199707243370410.
8
Low-dose interferon-alpha 2b combined with hydroxyurea versus hydroxyurea alone for chronic myelogenous leukemia.低剂量α-干扰素2b联合羟基脲与单用羟基脲治疗慢性粒细胞白血病的比较
Bone Marrow Transplant. 1996 May;17 Suppl 3:S19-20.
9
Randomized comparison of low-dose versus high-dose interferon-alfa in chronic myeloid leukemia: prospective collaboration of 3 joint trials by the MRC and HOVON groups.低剂量与高剂量干扰素-α治疗慢性髓性白血病的随机对照研究：MRC和HOVON组3项联合试验的前瞻性合作
Blood. 2004 Jun 15;103(12):4408-15. doi: 10.1182/blood-2003-10-3605. Epub 2004 Mar 9.
10
Interferon-alpha and hydroxyurea in early chronic myeloid leukemia: a comparative analysis of the Italian and German chronic myeloid leukemia trials with interferon-alpha.
Blood. 1996 Jun 15;87(12):5384-91.